articleTop 1% cited

International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation

Transplantation · 2010 · Vol. 89(7) · pp. 779–795

Camille N. Kotton✉(Massachusetts General Hospital)Deepali KumarAngela M. CaliendoAnders Åsberg(University of Oslo)Sunwen ChouDavid R. Snydman(October 6 University)Upton Allen(University of Toronto)Atul Humar

View via DOI Publisher page

Abstract

Cytomegalovirus (CMV) remains one of the most common infections after solid organ transplantation, resulting in significant morbidity, graft loss, and occasional mortality. Management of CMV varies considerably among transplant centers. A panel of experts on CMV and solid organ transplant was convened by The Infectious Diseases Section of The Transplantation Society to develop evidence and expert opinion-based consensus guidelines on CMV management including diagnostics, immunology, prevention, treatment, drug resistance, and pediatric issues.

Cytomegalovirus and herpesvirus research Renal Transplantation Outcomes and Treatments Transplantation: Methods and OutcomesCytomegalovirusSolid organOrgan transplantationCytomegalovirus infectionsValganciclovirBetaherpesvirinaeTransplantation

MeSH terms

AdultAntiviral AgentsChildConsensus Development Conferences as TopicConsensus Statements as TopicCytomegalovirus InfectionsHumansImmunosuppressive AgentsInternational CooperationRisk FactorsOrgan TransplantationTreatment OutcomeRisk AssessmentEvidence-Based MedicineCytomegalovirus Vaccines

Citations

961

FWCI

47.63

field-weighted impact

References

147

Percentile

100%

vs. same field & year

Citations per year

Cited by